Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine monotherapy vs combinations for malaria in Malawian children
NCT00379821Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Feb 2007
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of chloroquine in Plasmodium falciparum infection, sponsored by National Institute of Allergy and Infectious Diseases. Started Feb 2007; status: completed.
02
Drugs
chloroquine
03
Conditions
Plasmodium falciparum infection
Beyond the preview
Go deeper on NCT00379821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00379821.